[Clinical analysis of neuroendocrine carcinoma of the larynx].

L Chen,M Zhang,C Li,L Tao,S Y Wang,L Zhou
DOI: https://doi.org/10.13201/j.issn.1001-1781.2017.23.004
2017-01-01
Abstract:To evaluate the clinical manifestation, therapy and prognosis of neuroendocrine carcinoma of the larynx. Twenty-six cases with neuroendocrine carcinoma of the larynx were analyzed retrospectively. Four pathological types were found in our series: typical carcinoid (1/26), atypical carcinoid (15/26), small cell carcinoma, neuroendocrine type (9/26) and combined small cell carcinoma, neuroendocrine type (1/26). In this series, 12 cases were received total laryngectomy, 2 cases supracricoid partial laryngectomy-cricohyoidopexy (SCPL-CHP), 4 cases horizontal partial laryngectomy, 5 cases vertical partial laryngectomy, 1 case transoral CO₂ laser microsurgery, and 2 cases radiotherapy and/or chemotherapy. Three-year and five-year overall survival rates were 76.9% and 69.2% respectively. The neuroendocrine carcinoma of the larynx was rare, which was more common in the supraglottis. Atypical carcinoid was the most common pathological type. Compared to SCC, the clinical feature of neuroendocrine carcinoma of the larynx was non-specific. The clinical behavior, treatment,and prognosis were correlative to the tumor pathological.The diagnosis depended on comprehensive immunohistochemistry examination.
What problem does this paper attempt to address?